Endurance Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Endurance Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-300	Closed	-$14	–	496
2016 Q1	$14	Hold	300	–	–	﹤0.01%	361
2015 Q4	$16K	Hold	300	–	–	﹤0.01%	359
2015 Q3	$15K	Hold	300	–	–	﹤0.01%	364
2015 Q2	$17K	Buy	+300	New	+$17.5K	﹤0.01%	369

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

Endurance Wealth Management's IHE Position: Q2 2016 in Review

Endurance Wealth Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2016, closing a stake of 300 shares — an estimated $14 sold.

Endurance Wealth Management first reported a position in IHE in Q2 2015 and held it in 4 quarters. The position peaked at $17K in Q2 2015. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2016.

Endurance Wealth Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
Endurance Wealth Management sold 300 iShares US Pharmaceuticals ETF shares in Q2 2016, an estimated $14.
Endurance Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and held it in 4 quarters.
Endurance Wealth Management's iShares US Pharmaceuticals ETF position peaked at $17K in Q2 2015.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2016.

Based on Endurance Wealth Management's 13F filing for Q2 2016, filed 4 Aug 2016.